Petra Denig

4.5k total citations
181 papers, 3.2k citations indexed

About

Petra Denig is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Petra Denig has authored 181 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Economics and Econometrics, 67 papers in Geriatrics and Gerontology and 51 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Petra Denig's work include Pharmaceutical Practices and Patient Outcomes (67 papers), Health Systems, Economic Evaluations, Quality of Life (59 papers) and Medication Adherence and Compliance (38 papers). Petra Denig is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (67 papers), Health Systems, Economic Evaluations, Quality of Life (59 papers) and Medication Adherence and Compliance (38 papers). Petra Denig collaborates with scholars based in Netherlands, United Kingdom and Indonesia. Petra Denig's co-authors include Flora M. Haaijer‐Ruskamp, Jaco Voorham, Eelko Hak, Dick de Zeeuw, Sieta T. de Vries, Catharina C. M. Schuiling‐Veninga, Peter G. M. Mol, Grigory Sidorenkov, F. M. Haaijer-Ruskamp and Bruce H. R. Wolffenbuttel and has published in prestigious journals such as PLoS ONE, Diabetes Care and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Petra Denig

172 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra Denig Netherlands 31 960 897 687 641 634 181 3.2k
Jennifer Elston Lafata United States 38 602 0.6× 432 0.5× 770 1.1× 543 0.8× 1.0k 1.6× 159 4.7k
Andreas Sönnichsen Germany 29 555 0.6× 825 0.9× 377 0.5× 304 0.5× 676 1.1× 108 2.8k
Flora M. Haaijer‐Ruskamp Netherlands 36 1.2k 1.2× 1.4k 1.5× 350 0.5× 561 0.9× 965 1.5× 150 4.5k
Colin R. Dormuth Canada 35 1.2k 1.3× 408 0.5× 551 0.8× 470 0.7× 390 0.6× 115 4.3k
Richard H. Chapman United States 32 1.3k 1.4× 335 0.4× 488 0.7× 490 0.8× 528 0.8× 69 3.9k
Chester B. Good United States 38 1.1k 1.2× 617 0.7× 405 0.6× 380 0.6× 875 1.4× 186 5.0k
Luca Merlino Italy 32 851 0.9× 601 0.7× 539 0.8× 667 1.0× 275 0.4× 148 3.6k
Scot H. Simpson Canada 32 539 0.6× 802 0.9× 1.8k 2.5× 978 1.5× 410 0.6× 108 4.2k
Joseph J. Saseen United States 28 516 0.5× 822 0.9× 479 0.7× 357 0.6× 385 0.6× 152 3.1k
Colin McCowan United Kingdom 36 636 0.7× 626 0.7× 228 0.3× 571 0.9× 854 1.3× 135 4.2k

Countries citing papers authored by Petra Denig

Since Specialization
Citations

This map shows the geographic impact of Petra Denig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Denig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Denig more than expected).

Fields of papers citing papers by Petra Denig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Denig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Denig. The network helps show where Petra Denig may publish in the future.

Co-authorship network of co-authors of Petra Denig

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Denig. A scholar is included among the top collaborators of Petra Denig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Denig. Petra Denig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hugtenburg, Jacqueline G., et al.. (2025). Pharmacy-led interventions to reverse and prevent prescribing cascades in primary care: a proof-of-concept study. International Journal of Clinical Pharmacy. 47(3). 784–793. 1 indexed citations
2.
3.
Vos, Stijn de, et al.. (2024). Screening for Hypoglycaemia Risk and Medication Changes in Diabetes Patients Using Pharmacy Dispensing Data. Journal of Clinical Medicine. 13(19). 5855–5855.
4.
Vries, Sieta T. de, et al.. (2024). Willingness of people with type 2 diabetes to engage in healthy eating, physical activity and medication taking. Primary care diabetes. 18(3). 347–355. 2 indexed citations
5.
Vos, Stijn de, et al.. (2023). Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus. Pharmacoepidemiology and Drug Safety. 32(12). 1395–1405. 3 indexed citations
6.
Denig, Petra, et al.. (2023). Process evaluation of a pharmacist‐led intervention aimed at deprescribing and appropriate use of cardiometabolic medication among adult people with type 2 diabetes. Basic & Clinical Pharmacology & Toxicology. 134(1). 83–96. 5 indexed citations
7.
Vries, Sieta T. de, et al.. (2022). Sex disparities in medication prescribing amongst patients with type 2 diabetes mellitus managed in primary care. Diabetic Medicine. 40(1). e14987–e14987. 7 indexed citations
8.
Alfian, Sofa D., H Bos, Catharina C. M. Schuiling‐Veninga, et al.. (2020). Trends in polypharmacy and potentially inappropriate medication (PIM) in older and middle‐aged people treated for diabetes. British Journal of Clinical Pharmacology. 87(7). 2807–2817. 42 indexed citations
9.
Denig, Petra, et al.. (2019). Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States. PLoS ONE. 14(3). e0214240–e0214240. 51 indexed citations
10.
Denig, Petra, et al.. (2019). Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States. Pharmacoepidemiology and Drug Safety. 28. 533–534. 3 indexed citations
11.
Blanker, Marco H., et al.. (2017). Patient attitudes towards deprescribing of alpha-blockers and willingness to participate in a discontinuation trial. Neurourology and Urodynamics. 36. 242–244. 4 indexed citations
12.
Reeve, Emily, Petra Denig, Sarah N. Hilmer, & Ruud ter Meulen. (2016). The Ethics of Deprescribing in Older Adults. Journal of Bioethical Inquiry. 13(4). 581–590. 33 indexed citations
13.
Voorham, Jaco, Klaas van der Meer, Dick de Zeeuw, et al.. (2010). Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to aNalyse Type 2 diabetes Treatment (GIANTT) observational study. Pharmacoepidemiology and Drug Safety. 19(10). 1078–1086. 13 indexed citations
14.
Voorham, Jaco, et al.. (2010). [Quality of the treatment of type 2 diabetes: results from the GIANTT project 2004-2007].. PubMed. 154. A775–A775. 4 indexed citations
15.
Logtenberg, S. J. J., et al.. (2007). Consequenties van de nieuwe NHG-standaard type 2 diabetes mellitus voor de medicamenteuze bloeddruk-, (micro)albuminurie- en vetspectrumbehandeling (Zodiac-8). University of Groningen research database (University of Groningen / Centre for Information Technology). 5. 51–57. 1 indexed citations
16.
Denig, Petra, et al.. (2005). Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?. BMC Family Practice. 6(1). 19–19. 20 indexed citations
17.
Denig, Petra, et al.. (2004). Patient, doctor, and organisational factors affecting hypertension management in patients with type 2 diabetes. British Journal of Clinical Pharmacology. 57(3). 357–357. 2 indexed citations
18.
Denig, Petra, et al.. (2002). Specialists' expectations regarding joint treatment guidelines for primary and secondary care. International Journal for Quality in Health Care. 14(6). 509–518. 18 indexed citations
19.
Schuiling‐Veninga, Catharina C. M., Rolf Wahlström, Petra Denig, et al.. (1999). Evaluating an Educational Intervention to Improve the Treatment of Asthma in Four European Countries. American Journal of Respiratory and Critical Care Medicine. 160(4). 1254–1262. 74 indexed citations
20.
Haaijer-Ruskamp, F. M. & Petra Denig. (1995). Impact of feedback and peer review on prescribing.. 13–19. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Elston Lafata Breakdown of academic impact, for papers by Andreas Sönnichsen Breakdown of academic impact, for papers by Flora M. Haaijer‐Ruskamp Breakdown of academic impact, for papers by Colin R. Dormuth Breakdown of academic impact, for papers by Richard H. Chapman Breakdown of academic impact, for papers by Chester B. Good Breakdown of academic impact, for papers by Luca Merlino Breakdown of academic impact, for papers by Scot H. Simpson Breakdown of academic impact, for papers by Joseph J. Saseen Breakdown of academic impact, for papers by Colin McCowan
Rankless by CCL
2026